Cargando…
Discovery of actionable genetic alterations with targeted panel sequencing in children with relapsed or refractory solid tumors
Advances in genomic technologies and the development of targeted therapeutics are making the use of precision medicine increasingly possible. In this study, we explored whether precision medicine can be applied for the management of refractory/relapsed pediatric solid tumors by discovering actionabl...
Autores principales: | Lee, Ji Won, Kim, Nayoung K. D., Lee, Soo Hyun, Cho, Hee Won, Ma, Youngeun, Ju, Hee Young, Yoo, Keon Hee, Sung, Ki Woong, Koo, Hong Hoe, Park, Woong-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6867621/ https://www.ncbi.nlm.nih.gov/pubmed/31747416 http://dx.doi.org/10.1371/journal.pone.0224227 |
Ejemplares similares
-
Treatment Outcomes in Children and Adolescents with Relapsed or Progressed Solid Tumors: a 20-year, Single-Center Study
por: Cho, Hee Won, et al.
Publicado: (2018) -
DNA-thioguanine nucleotide as a treatment marker in acute lymphoblastic leukemia patients with NUDT15 variant genotypes
por: Ju, Hee Young, et al.
Publicado: (2021) -
Optimal Time to Start Peripheral Blood Stem Cell Collection in Children with High-Risk Solid Tumors
por: Sung, Ki Woong, et al.
Publicado: (2014) -
Incorporation of high-dose (131)I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study
por: Lee, Ji Won, et al.
Publicado: (2017) -
Detection of MYCN Amplification in Serum DNA Using Conventional Polymerase Chain Reaction
por: Ma, Youngeun, et al.
Publicado: (2016)